WAYNE, Pa., Dec. 7, 2016 /PRNewswire/ -- Bracket, a leading clinical trial technology and specialty services provider with expertise in Alzheimer's disease (AD), announced that its Scientific Advisory Board (SAB) has formed an AD sub-committee that will hold its inaugural meeting at the 9th Annual Clinical Trials on Alzheimer's Disease (CTAD) conference on December 8 – 10, 2016 in San Diego, California.
The sub-committee, chaired by and established in collaboration with Jeffrey Cummings, M.D., Sc.D., Director of Cleveland Clinic's Lou Ruvo Center for Brain Health and Camille and Larry Ruvo Chair of the Neurological Institute of Cleveland Clinic, will focus exclusively on maintaining Bracket's awareness and involvement in AD research advancement, field changes, emerging technologies and competitive landscape.
As a specialty services provider with specific expertise in AD trial technology, including the development and launch of Bracket eCOASM, Bracket's sub-committee will build upon the Company's strategic agenda to capture data using technology, finding innovative ways to minimize error-prone human factors in clinical trials. The committee will be critical in assessing the acceptability of new technologies to sites.
"Bracket's SAB is well-represented across various therapeutic areas, but we maintain a specialized focus on AD in effort to combat the many challenges facing its clinical trials today," said Jeff Kinell, CEO of Bracket. "We've invested tremendously on improving outcomes in the area and we're hopeful that this focused sub-committee will connect the right data, minds and initiatives to move AD trials forward."
With plans to meet several times per year at relevant meetings such as American Academy of Neurology Annual Meeting and Alzheimer's Association International Conference, the committee will share meeting notes and coordinate on common projects with Bracket's SAB, while operating independently. The SAB is currently chaired by Dr. Charles Nemeroff, M.D., Ph.D. and Dr. Jeffrey A.Lieberman, M.D.
To learn more about Bracket, visit www.bracketglobal.com.
Bracket, with nine offices and more than 700 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs. Learn more about Bracket at www.bracketglobal.com.
Sagefrog Marketing Group on behalf of Bracket
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/brackets-new-sab-sub-committee-for-alzheimers-disease-to-hold-inaugural-meeting-at-ctad-2016-300374549.html